Article Text

Download PDFPDF
Haemoglobin Fontainebleau (HBA2: c. 64G>C) in Oman: molecular and haematological characteristics and interaction with various haemoglobinopathies
  1. Shahina Daar1,
  2. Shoaib Al Zadjali2,
  3. Salam Alkindi1,
  4. Yasser Wali1,
  5. Abdulhakeem Al-Rawas2,
  6. Humood Al-Haddabi1,
  7. Arwa Z Al-Riyami2
  1. 1 Department of Haematology, Sultan Qaboos University, Muscat, Oman
  2. 2 Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman
  1. Correspondence to Dr Shoaib Al Zadjali, Sultan Qaboos University Hospital, PO Box 38, PC 123, Muscat, OMAN; shoaibzad{at}


Objectives To describe the laboratory features of haemoglobin Fontainebleau (Hb FB) and its interactions with various α and β globin gene mutations in the Omani population.

Methods Over a period of 10 years, a total of 94 blood samples were suspected to have an α variant on HPLC at the Sultan Qaboos University Hospital, Muscat, Oman. Molecular testing was performed using PCR based techniques to define the variant and to analyse other interacting mutations in either α or β globin genes.

Results Of 94 subjects, molecular analysis confirmed the Hb FB variant in 55 samples (38 non-cord and 17 cord blood). A total of 36/38 non-cord samples were heterozygous for the variant, while all 17 cord blood samples were heterozygotes. A total of 43/55 individuals had a concomitant α and/or β globin gene mutation.

Conclusions Hb FB is the the most common α variant in the Omani population. We report the different HPLC profiles of this variant that we observed, with and without other haemoglobinopathies in non-cord and cord blood samples. This is the first report describing the HPLC profiles of this α globin chain variant on 1 year follow-up testing of cord blood samples. With careful analysis by HPLC, it is possible not only to identify Hb FB but also to predict any concomitant α and/or β globin gene mutations.

  • Haemoglobinopathy
  • Diagnosis
  • Diagnostic Screening

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Handling editor Mary Frances McMullin.

  • Competing interests None declared.

  • Ethics approval The study was approved by the ethics committee at the College of Medicine and Health Sciences at Sultan Qaboos University, Oman.

  • Provenance and peer review Not commissioned; externally peer reviewed.